Ide-cel versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): A KarMMa-3 analysis in the modified intention to-treat (mITT) population Meeting Abstract
| Authors: | Manier, S.; Ailawadhi, S.; Rodríguez-Otero, P.; Arnulf, B.; Patel, K.; Solomon, S.; Baz, R.; Jagannath, S.; Raje, N.; Scheid, C.; Mateos, M. V.; Abdallah, A.; Einsele, H.; Giralt, S.; Pabst, T. M.; Perrot, A.; Lin, Y.; Truppel-Hartmann, A.; Bhatnagar, R.; Felten, J.; Caia, A.; Piasecki, J.; Cook, M.; Moreau, P. |
| Abstract Title: | Ide-cel versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): A KarMMa-3 analysis in the modified intention to-treat (mITT) population |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S51 |
| Language: | English |
| ACCESSION: | WOS:001079705400084 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01650-6 |
| Notes: | Meeting Abstract: P-032 -- Source: Wos |
